THE FOOD AND DRUG Administration recommends monitoring coronavirus vaccine recipients for Bell’s palsy as the shots roll out, but the agency at this time does not have enough evidence to link the condition to the inoculations.
While there were rare instances in which trial participants for both the Pfizer and Moderna coronavirus vaccines experienced the condition, which can cause a weakness or paralysis in the face that typically resolves itself within six months, the agency has said that the rate it occurred in the trials is consistent with the background rate in the general population.
Comments
